JCR Pharmaceuticals Co.,Ltd. (4552)

Market cap
¥63.8B
P/E ratio
27.5x
JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.
Period EndPretax margin (%) YoY (%)
Mar 31, 20261.8-108.17%
Mar 31, 2025-22.6-233.43%
Mar 31, 202416.9+7.40%
Mar 31, 202315.8-60.71%
Mar 31, 202240.2+42.33%
Mar 31, 202128.2+112.32%
Mar 31, 202013.3-39.27%
Mar 31, 201921.9+17.26%
Mar 31, 201818.7+33.16%
Mar 31, 201714+0.03%
Mar 31, 201614+0.90%
Mar 31, 201513.9+29.73%
Mar 31, 201410.7+30.51%
Mar 31, 20138.2+4.76%
Mar 31, 20127.8
AI Chat